Benjamin Tomlinson

13PUBLICATIONS
49CO-AUTHORS
Gene and molecular therapyRespiratory diseasesHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 16, 2026
Efficacy of skin microvasculature C5b-9 and MASP2 deposition in transplant-associated thrombotic microangiopathy.

|Feb 03, 2026
ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysis.

Joseph O'Brien, Ben Tomlinson, Mayher J Patel

|Oct 08, 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemias.

Sudipta Biswas, Zeinab Albadry M Zahran, Xiaorong Gu

|Sep 19, 2024
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian

|Jan 03, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.

Leland L Metheny, Ronald Sobecks, Christina Cho

|Aug 21, 2023
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.

Mikkael A Sekeres, Pau Montesinos, Jan Novak

Pageof 3

Frequent Collaborators

2 joint publications

Hillard M Lazarus

2 joint publications

Koen Van Besien

2 joint publications

Sergio Giralt

2 joint publications

Paolo F Caimi